Awards & ESG Excelya has earned EcoVadis Bronze Medal and was recognized as top 35% of evaluated companies, signaling credibility in sustainability and responsible business practices that can be leveraged in conversations with risk-averse clients.

Global CRO Footprint With operations in 28 countries across Europe, the USA, and India and a global team of 900+ experts, Excelya offers multinational trial capabilities and local execution expertise suitable for large biotech and pharma programs seeking regional and cross-border studies.

Therapeutic Specialties Special focus areas include Oncology & Hematology, Rare Disease & Pediatrics, Infectious Disease, Inflammation & Immunotherapy, Pain/CNS, and Late Phase & Real World Evidence, aligning opportunities with high-growth therapeutic areas and late-stage expansion needs.

Strategic Services Full-service CRO, FSP, and resourcing solutions present opportunities for clients seeking flexible engagement models, pilot programs, or scale-up of clinical operations, particularly for sponsors requiring rapid, bespoke trial solutions.

Financial & Growth Signals Revenue range ($100M-$250M) and a history of leadership appointments indicate a scaling CRO with potential for increased outsourcing demand, making Excelya a candidate for expanded partnerships, especially in mid-to-large biotech pipelines.